Change - Announcement of Appointment::REDESIGNATION OF SENIOR NURSE EXECUTIVE TO CHIEF NURSING OFFICER

Issuer & Securities

Issuer/ Manager
HC SURGICAL SPECIALISTS LIMITED
Securities
HC SURGICAL SPECIALISTSLIMITED - SG1DC2000004 - 1B1
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
28-Feb-2022 12:17:40
Status
New
Announcement Sub Title
REDESIGNATION OF SENIOR NURSE EXECUTIVE TO CHIEF NURSING OFFICER
Announcement Reference
SG220228OTHRPOZG
Submitted By (Co./ Ind. Name)
Dr. Heah Sieu Min
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Redesignation of Ms. Cai Tingting ("Ms. Cai") from Senior Nurse Executive to Chief Nursing Officer with effect from 1 March 2022.

HC Surgical Specialists Limited (the "Company") was incorporated on 1 September 2015 in Singapore and listed on Catalist of the Singapore Exchange Securities Trading Limited on 3 November 2016. The Company, its subsidiaries and associated company are a medical services group primarily engaged in the provision of endoscopic procedures, including gastroscopies and colonoscopies, and general surgery services with a focus on colorectal procedures across a network of 16 clinics located throughout Singapore.

This announcement has been prepared by the Company and reviewed by the Company's sponsor, Novus Corporate Finance Pte. Ltd. (the "Sponsor"), in compliance with Rule 226(2)(b) of the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist.

This announcement has not been examined or approved by the SGX-ST and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made, or reports contained in this announcement.

The contact person for the Sponsor is Mr. Pong Chen Yih, Chief Operating Officer, at 7 Temasek Boulevard, #18-03B Suntec Tower 1, Singapore 038987, telephone (65) 6950 2188.

Additional Details

Date Of Appointment
01/03/2022
Name Of Person
Cai Tingting
Age
39
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Ms. Cai was previously the Chief Nursing Officer (the "CNO") from 1 March 2018 to 14 November 2021. She relinquished her CNO role with effect from 15 November 2021, but remained in the Group as Senior Nurse Executive upon her request to reduce her work commitments for personal reasons. She is now able to commit to her CNO responsibilities.

Ms. Cai was recommended by the Nominating Committee of the Company and approved by the Company's board of directors (the "Board") based on her qualifications and work experience. The Board has reviewed the qualifications and experience of Ms. Cai and is of the view that her nursing experience will contribute positively to the nursing standards of the Company and its subsidiaries (the "Group"). Furthermore, Ms. Cai was the CNO of the Company for the period 1 March 2018 to 14 November 2021.
Whether appointment is executive, and if so, the area of responsibility
Yes. The area of responsibility includes upholding the Group's nursing standards in accordance to the guidelines under the Ministry of Health, in addition to overseeing the Group's marketing plans.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Nursing Officer
Professional qualifications
Diploma in Nursing from Nanyang Polytechnic
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
15 November 2021 to present
Senior Nurse Executive of the Company

1 March 2018 - 14 November 2021
Chief Nursing Officer of the Company

1 August 2016 to 28 February 2018
Operations and Marketing Manager of the Company

1 September 2008 to 31 July 2016
Clinic Nurse of Heah Sieu Min (Bukit Batok) Pte. Ltd. (subsidiary of the Company)
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
None
Present
None
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Not applicable
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable